HIGHLIGHTS
- who: Sizhou Feng and collaborators from the State Key Laboratory of Experimental Hematology, Haihe Laboratory Heping District, Tianjin, China University, National Clinical Research Center for Hematologic Diseases have published the Article: RESEARCH Open Access, in the Journal: (JOURNAL)
- what: The authors aimed to assess the efficacy of autologous HSCT in patients with favorable-risk acute myeloid leukemia in first remission.
SUMMARY
According to the ELN risk stratification by genetics, acute myeloid leukemia (AML) can be categorized into favorable-risk, intermediate-risk and adverse-risk groups. For patients in the favorable-risk . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.